ZA83224B - New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives - Google Patents

New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives

Info

Publication number
ZA83224B
ZA83224B ZA83224A ZA83224A ZA83224B ZA 83224 B ZA83224 B ZA 83224B ZA 83224 A ZA83224 A ZA 83224A ZA 83224 A ZA83224 A ZA 83224A ZA 83224 B ZA83224 B ZA 83224B
Authority
ZA
South Africa
Prior art keywords
triazolo
new
derivatives
phtalazine
substituted
Prior art date
Application number
ZA83224A
Other languages
English (en)
Inventor
Emilio Occelli
Domenico Barone
Giorgio Tarzia
Adele Giunta
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of ZA83224B publication Critical patent/ZA83224B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
ZA83224A 1982-01-18 1983-01-13 New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives ZA83224B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18

Publications (1)

Publication Number Publication Date
ZA83224B true ZA83224B (en) 1983-10-26

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83224A ZA83224B (en) 1982-01-18 1983-01-13 New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives

Country Status (20)

Country Link
US (1) US4788186A (fi)
EP (1) EP0085840B1 (fi)
JP (1) JPS58124786A (fi)
KR (1) KR890000184B1 (fi)
AT (1) ATE22562T1 (fi)
AU (1) AU564026B2 (fi)
CA (1) CA1214168A (fi)
DE (1) DE3366494D1 (fi)
DK (1) DK163145C (fi)
ES (1) ES8601995A1 (fi)
FI (1) FI81350C (fi)
GR (1) GR78442B (fi)
HU (1) HU193033B (fi)
IE (1) IE55032B1 (fi)
IL (1) IL67697A (fi)
NO (1) NO161674C (fi)
NZ (1) NZ203021A (fi)
PH (1) PH21834A (fi)
PT (1) PT76107A (fi)
ZA (1) ZA83224B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
AU724076B2 (en) * 1996-07-25 2000-09-14 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype
SK9399A3 (en) 1996-07-25 2000-04-10 Merck Sharp & Dohme Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
EP0986562B1 (en) 1997-05-08 2002-08-07 MERCK SHARP & DOHME LTD. Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
GB9715977D0 (en) 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
US6303597B1 (en) 1998-01-14 2001-10-16 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
CA2315763A1 (en) 1998-01-21 1999-07-29 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
US6448249B1 (en) 1998-02-25 2002-09-10 Merck Sharp & Dohme Ltd. Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
EP1070066A1 (en) * 1998-02-25 2001-01-24 MERCK SHARP & DOHME LTD. SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a]PYRIDAZINE
JP2002529468A (ja) 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド ＧＡＢＡ−Ａα−５逆活性薬の治療性多形およびそのパモエート組成物
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
EP1379250A2 (en) * 2001-04-10 2004-01-14 Merck & Co., Inc. A method of treating cancer
US6958334B2 (en) * 2001-04-10 2005-10-25 Merck & Co., Inc. Inhibitors of Akt activity
WO2003084473A2 (en) * 2002-04-08 2003-10-16 Merck & Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
ATE471324T1 (de) * 2004-09-02 2010-07-15 Nycomed Gmbh Triazolophthalazine
JP5130053B2 (ja) * 2005-01-05 2013-01-30 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
CN101103033B (zh) 2005-01-05 2010-08-04 尼科梅德有限责任公司 作为pde2抑制剂的三唑并酞嗪
SG182297A1 (en) 2009-12-31 2012-08-30 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (fi) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
DE3366494D1 (de) 1986-11-06
PT76107A (en) 1983-02-01
DK17983A (da) 1983-07-19
IE55032B1 (en) 1990-05-09
JPS58124786A (ja) 1983-07-25
ES531458A0 (es) 1985-11-01
ATE22562T1 (de) 1986-10-15
FI830100L (fi) 1983-07-19
US4788186A (en) 1988-11-29
AU1055083A (en) 1983-07-28
FI81350B (fi) 1990-06-29
KR890000184B1 (ko) 1989-03-09
JPH048428B2 (fi) 1992-02-17
NO161674C (no) 1989-09-13
AU564026B2 (en) 1987-07-30
KR840003254A (ko) 1984-08-20
NO830110L (no) 1983-07-19
HU193033B (en) 1987-08-28
NO161674B (no) 1989-06-05
PH21834A (en) 1988-03-17
DK163145C (da) 1992-06-22
GR78442B (fi) 1984-09-27
EP0085840B1 (en) 1986-10-01
IL67697A0 (en) 1983-05-15
IE830082L (en) 1983-07-18
FI830100A0 (fi) 1983-01-12
EP0085840A1 (en) 1983-08-17
IL67697A (en) 1990-02-09
FI81350C (fi) 1990-10-10
CA1214168A (en) 1986-11-18
DK163145B (da) 1992-01-27
DK17983D0 (da) 1983-01-18
NZ203021A (en) 1986-05-09
ES8601995A1 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
ZA83224B (en) New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives
GB2050828B (en) Process for the preparations of finely divided pharmaceutical compositions
DE3361803D1 (en) Process for the preparation of (2,2)-paracyclophane
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PT76160A (en) Process for the preparation of herbicide derivatives of cyclohexano-1,3-dione and herbicide compositions therewith
IL68680A (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3260932D1 (en) Process for the preparation of derivatives of resorcin, and the use of certain derivatives of resorcin as perfumes
ZA83772B (en) Substituted thienobenzodiazepinones,processes for the preparations thereof and pharmaceutical compositions containing these compounds
PT79389B (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
DE3365690D1 (en) Process for the preparation of 3,4,9,10-tetrathioperylene and 3,4,9,10-tetraselenoperylene
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
PT76110B (en) Process for the preparation of 3,3-dialkyl indoline and 3,3-alkylene-indoline derivatives and of pharmaceutical compositions containing them
DE3361151D1 (en) Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
DE3368933D1 (en) Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
PT74400A (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PT79451A (en) Process for the preparation of dust-free quinoxaline 1,4-di-n-oxides
EP0099071A3 (en) Process for the preparation of monoaroylated 1,4-diaminoanthraquinones
GB8314158D0 (en) Process for the preparation of 1,1-bisphenyl-2-haloalkan-1-ols
DE3264533D1 (en) Process for the preparation of 1,1-bis phenyl-2-haloalkan-1-ols
DE3374683D1 (en) Process for the preparation of 6-exo-alkanoyl-1,3,3-trimethyl-bicyclo(2.2.2.)octan-2-ones
SG88994G (en) Process for the preparation of anti-oxidant compositions.